Aberdeen Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $912K | Sell |
17,951
-1,274
| -7% | -$59.4K | ﹤0.01% | 831 |
|
|
2025
Q4 | $567K | Hold |
19,225
| – | – | ﹤0.01% | 875 |
|
|
2025
Q3 | $497K | Sell |
19,225
-62,274
| -76% | -$1.74M | ﹤0.01% | 894 |
|
|
2025
Q2 | $2.25M | Buy |
81,499
+1,482
| +2% | +$39K | ﹤0.01% | 774 |
|
|
2025
Q1 | $2.27M | Sell |
80,017
-235,895
| -75% | -$8.37M | ﹤0.01% | 750 |
|
|
2024
Q4 | $12.8M | Buy |
315,912
+69,360
| +28% | +$3.32M | 0.02% | 464 |
|
|
2024
Q3 | $16.3M | Sell |
246,552
-46,110
| -16% | -$4.23M | 0.03% | 432 |
|
|
2024
Q2 | $34.8M | Sell |
292,662
-170,452
| -37% | -$21.6M | 0.07% | 267 |
|
|
2024
Q1 | $49.3M | Sell |
463,114
-20,460
| -4% | -$2.06M | 0.1% | 221 |
|
|
2023
Q4 | $48.1M | Buy |
483,574
+399,843
| +478% | +$33.6M | 0.1% | 212 |
|
|
2023
Q3 | $8.65M | Sell |
83,731
-5,374
| -6% | -$599K | 0.02% | 473 |
|
|
2023
Q2 | $10.8M | Sell |
89,105
-3,509
| -4% | -$468K | 0.03% | 461 |
|
|
2023
Q1 | $14.2M | Sell |
92,614
-1,527
| -2% | -$252K | 0.04% | 401 |
|
|
2022
Q4 | $16.9M | Buy |
94,141
+8,061
| +9% | +$1.32M | 0.05% | 367 |
|
|
2022
Q3 | $10.2M | Sell |
86,080
-15,293
| -15% | -$2.32M | 0.03% | 428 |
|
|
2022
Q2 | $14.6M | Sell |
101,373
-1,025
| -1% | -$147K | 0.05% | 353 |
|
|
2022
Q1 | $17.9M | Sell |
102,398
-15,161
| -13% | -$2.55M | 0.05% | 326 |
|
|
2021
Q4 | $29.9M | Sell |
117,559
-5,048
| -4% | -$1.48M | 0.07% | 271 |
|
|
2021
Q3 | $47.2M | Buy |
122,607
+90,699
| +284% | +$33.5M | 0.11% | 197 |
|
|
2021
Q2 | $7.5M | Buy |
31,908
+74
| +0.2% | +$13.2K | 0.02% | 565 |
|
|
2021
Q1 | $4.17M | Buy |
31,834
+457
| +1% | +$66.2K | 0.01% | 679 |
|
|
2020
Q4 | $3.28M | Buy |
31,377
+2,855
| +10% | +$289K | 0.01% | 680 |
|
|
2020
Q3 | $2.02M | Buy |
28,522
+12,695
| +80% | +$885K | 0.01% | 704 |
|
|
2020
Q2 | $1.02M | Buy |
+15,827
| New | +$867K | ﹤0.01% | 776 |
|
Other funds holding MRNA
VCM
VPM
